ipsen
Ipsen bolsters executive leadership with two new recruits
April 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Ipsen is set to expand its executive leadership team with the announcement of two new recruitments: Dr Ivana Magovčević-Liebisch will …
Top Ten most popular articles on Pharmafile.com this week
March 2, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, Alzheimer's, AstraZeneca, Botox, Celgene, EMA, FDA, Merck, Mylan, Pfizer, Roche, Takeda, ipsen, vaccines
We’re already into March and, trying to put a bad start to the year behind them on Alzheimer’s research, the …
Ipsen: Becoming a “development powerhouse”
March 1, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing David Meek, Insider Interview, ipsen, pharma
Immediately following the release of impressive full year financials, Ipsen CEO David Meek speaks on how the company is hitting …
NICE recommends thyroid cancer drug trio for NHS use
February 20, 2018Manufacturing and Production, Sales and Marketing Bayer, Cancer, Cometriq, Eisai, Lenvima, NICE, Nexavar, ipsen, pharma, thyroid cancer
NICE has announced its decision to recommend that three separate treatments for thyroid cancer should be made available for use …
Ipsen promotes new CMO from within
January 31, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen has announced that Sotirios G. Stergiopoulos will become its newest Chief Medical Officer, performing the role alongside his current …
Ipsen ends P3 trial on liver cancer early due to strong data
January 18, 2018Research and Development Cabometyx, Exelixis, biotech, drugs, ipsen, pharma, pharmaceutical
Ipsen and Exelixis, partners in developing Cabometyx (cabozantinib), have revealed that they have cut short a Phase 3 trial into …
Dr Aidan Murphy becomes Ipsen’s new Executive VP, Technical Operations
January 10, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen, pharma
Dr Aidan Murphy has been named by Ipsen’s new Executive Vice President, Technical Operations, succeeding Jonathan Barnsley who retired at …
Ipsen announces new Vice President of Corporate External Communications
September 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen
French biopharmaceutical group Ipsen has announced that Dr Ian Weatherhead has taken up the position of Vice President, Corporate External …
Ipsen appoints new Executive Vice President
March 2, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ipsen
Ipsen has announced the appointment of Benoit Hennion as Executive Vice President and President of Primary Care. Hennion has worked …
NICE provisionally rejects Ipsen’s kidney cancer drug Cabometyx
February 21, 2017Manufacturing and Production, Sales and Marketing Cometriq, NICE, ipsen
NICE has announced draft guidance for Ipsen’s cancer drug Cabometyx (cabozantinib), revealing it does not recommend the drug for use on …
Ipsen to acquire Sanofi assets in $88 million deal
February 13, 2017Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen
Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …
Ex-Novartis exec joins Ipsen as President, Head of Specialty Care
February 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen
Harout Semerjian has joined French pharma firm Ipsen as President, Head of Specialty Care International Region & Global Franchises, the …
Ipsen names new Head of Global Medical Affairs
February 8, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointment, ipsen
French pharmaceutical firm Ipsen has announced its recruitment of Dr Sotirios Stergiopoulos as its Senior Vice President and Head of …
Merrimack sells off drug for $1 billion and cuts workforce by 80%
January 9, 2017Sales and Marketing Onivyde, ipsen, merrimack
Ipsen has announced the agreement to acquire oncology assets from Merrimack Pharmaceuticals, most notably the pancreatic cancer drug Onivyde, in …
Ipsen and PeptiMimesis announce oncology research partnership
March 9, 2016Research and Development INSERM, PeptiMimesis, ipsen, peptides
Specialist pharma company Ipsen is partnering with French start-up PeptiMimesis to develop and market of novel therapeutic peptides in oncology. …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
